Aroa Biosurgery names Michael Lynskey chief commercial officer

Reuters2026/07/28 05:03

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aroa Biosurgery named Michael Lynskey chief commercial officer on July 28, 2026, tasking him with leading global commercial growth.
Lynskey brings 20+ years in advanced wound healing; he joins from Smith+Nephew, following earlier roles at Stryker, Johnson & Johnson.
Mike Falcon was appointed general manager, US commercial, to lead the U.S. commercial organization as the company expands its presence.
Falcon previously held commercial leadership roles at LifeNet Health; earlier positions included Biomet, Johnson & Johnson.
Moves add senior leadership to support momentum in the Myriad portfolio, targeting increased opportunity for the Symphony outpatient product.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aroa Biosurgery Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607280103PR_NEWS_USPR_____CN13561) on July 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Aroa Biosurgery names Michael Lynskey chief commercial officer

You may also like

Crypto prices